Bio-Thera Solutions Ltd (688177) - Cash Flow Conversion Efficiency

Latest as of June 2023: -0.054x

Based on the latest financial reports, Bio-Thera Solutions Ltd (688177) has a cash flow conversion efficiency ratio of -0.054x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-72.53 Million ≈ $-10.61 Million USD) by net assets (CN¥1.35 Billion ≈ $198.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Bio-Thera Solutions Ltd (688177) liquidity interval to measure how many days the company can operate on defensive assets alone.

Bio-Thera Solutions Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Bio-Thera Solutions Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bio-Thera Solutions Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bio-Thera Solutions Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Tianjin Ringpu Bio Tech SHE:300119	0.020x
Zhejiang Guyuelongshan Shaoxing Wine Co Ltd SHG:600059	-0.006x
Bangkok Chain Hospital Public Company Limited BK:BCH-R	0.032x
Sunflower Pharmaceuticals Group Co Ltd SHE:002737	-0.029x
Jiangsu Yinhe Electronics Co Ltd SHE:002519	-0.009x
Shunfa Hengye Corp SHE:000631	0.000x
Hbt Financial Inc NASDAQ:HBT	0.032x
Inner Mongolia ERDOS Resources Co Ltd B SHG:900936	0.075x

Annual Cash Flow Conversion Efficiency for Bio-Thera Solutions Ltd (2016–2025)

The table below shows the annual cash flow conversion efficiency of Bio-Thera Solutions Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see 688177 company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥376.03 Million ≈ $55.03 Million	CN¥-82.11 Million ≈ $-12.02 Million	-0.218x	-177.83%
2024-12-31	CN¥708.09 Million ≈ $103.62 Million	CN¥-55.65 Million ≈ $-8.14 Million	-0.079x	+79.32%
2023-12-31	CN¥1.21 Billion ≈ $177.46 Million	CN¥-460.87 Million ≈ $-67.44 Million	-0.380x	-47.96%
2022-12-31	CN¥1.61 Billion ≈ $235.19 Million	CN¥-412.82 Million ≈ $-60.41 Million	-0.257x	-326.93%
2021-12-31	CN¥2.09 Billion ≈ $305.47 Million	CN¥236.27 Million ≈ $34.57 Million	0.113x	+163.40%
2020-12-31	CN¥2.01 Billion ≈ $293.48 Million	CN¥-358.04 Million ≈ $-52.39 Million	-0.179x	+81.17%
2019-12-31	CN¥630.67 Million ≈ $92.29 Million	CN¥-597.98 Million ≈ $-87.50 Million	-0.948x	-43.83%
2018-12-31	CN¥801.32 Million ≈ $117.26 Million	CN¥-528.25 Million ≈ $-77.30 Million	-0.659x	+3.20%
2017-12-31	CN¥347.55 Million ≈ $50.86 Million	CN¥-236.68 Million ≈ $-34.63 Million	-0.681x	-213.27%
2016-12-31	CN¥534.43 Million ≈ $78.20 Million	CN¥-116.18 Million ≈ $-17.00 Million	-0.217x	--

About Bio-Thera Solutions Ltd

SHG:688177 China Biotechnology

Market Cap

$1.03 Billion

CN¥7.06 Billion CNY

Market Cap Rank

#8927 Global

#2249 in China

Share Price

CN¥17.06

Change (1 day)

+4.22%

52-Week Range

CN¥16.37 - CN¥34.72

All Time High

CN¥71.90